Clinical Trials Directory

Trials / Sponsors / Rhodes Pharmaceuticals, L.P.

Rhodes Pharmaceuticals, L.P.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
UnknownA 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
Attention Deficit Disorder With Hyperactivity
Phase 42016-09-01
CompletedPharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age W
Attention-Deficit/Hyperactivity Disorder
Phase 42016-07-30
CompletedA Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD
Attention Deficit Disorder With Hyperactivity
Phase 42016-04-25
CompletedA Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
Attention Deficit Hyperactivity Disorder
Phase 32015-09-01
CompletedPRC-063 in an ADULT Workplace Environment
Attention Deficit Hyperactivity Disorder (ADHD)
Phase 32014-08-01
CompletedLong-Term Safety of PRC-063 in Adolescents and Adults With ADHD
ADHD
Phase 32014-05-01
CompletedThe Efficacy and Safety of PRC-063 in Adult ADHD Patients
ADHD
Phase 32014-04-01
CompletedPRC-063 in Adolescent ADHD
ADHD
Phase 32014-04-01
CompletedSafety and Efficacy of PG101 for Dry Eye Syndrome
Dry Eye Syndrome
Phase 1 / Phase 22013-12-01
CompletedTime Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Se
Attention Deficit Hyperactivity Disorder, ADHD
Phase 32011-01-19
CompletedEfficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Attention Deficit Hyperactivity Disorder, ADHD
Phase 32010-11-01